Abstract
In the absence of an apoptotic signal, BAX adopts a conformation that constrains the protein from integrating into mitochondrial membranes. Here, we show that caspases, including caspase-8, can initiate BAX insertion into mitochondria in vivo and in vitro. The cleavage product of caspase-8, tBID, induced insertion of BAX into mitochondria in vivo, and reconstitution in vitro showed that tBID, either directly or indirectly, relieved inhibition of the BAX transmembrane signal-anchor by the NH2-terminal domain, resulting in integration of BAX into mitochondrial membrane. In contrast to these findings, however, Bid-null mouse embryo fibroblasts supported Bax insertion into mitochondria in response to death signaling by either TNFα or E1A, despite the fact that cytochrome c release from the organelle was inhibited. We conclude, therefore, that a parallel Bid-independent pathway exists in these cells for mitochondrial insertion of Bax and that, in the absence of Bid, cytochrome c release can be uncoupled from Bax membrane insertion. Cell Death and Differentiation (2000) 7, 1101–1108
Similar content being viewed by others
Introduction
Induction of apoptotic pathways in response to death signals is critically dependent on the status of survival/death regulators within a cell. Prominent among these is the BCL-2 family of anti-apoptotic (BCL-2, BCL-XL, BCL-w, MCL-1, A-1) and pro-apoptotic (BAX, BAK, BOK) members, whose activities and ability to form heterodimers is influenced by a third subgroup of the BCL-2 family, which includes mammalian BID, BAD, BIK, BIM, BLK, HRK, and C. elegans EGL-1.1,2 The latter are proapoptotic and contain a minimal apoptotic domain, BH3, which targets these proteins for interaction with BCL-2 proteins. Several of these ‘BH3 domain only’ members, including BID, BAD, and BIM, are themselves influenced by specific signal transduction pathways,3,4,5,6,7 which serve to link the BCL-2·BAX checkpoint to upstream cell-death initiating events. BCL-2 and BAX each contain a single transmembrane segment at their extreme COOH-terminus, which is responsible for targeting these proteins into membrane sites, including mitochondria,8,9,10 where their opposing functions influence organellar integrity and function.11 In situations where anti-apoptotic BCL-2 members are limiting, mitochondria undergo profound dysfunction in response to most death signals. This includes release of cytochrome c from the intermembrane space,12,13 which triggers activation of downstream caspases,14 and ultimately induction of permeability transition at the inner membrane, resulting in loss of the electrochemical potential and production of excess reactive oxygen species.11 Recently, mitochondrial transformations have been directly linked to cleavage of cytosolic BID by caspases, including caspase-8, in the CD95/Fas and TNFR1 cell death pathways, at least in certain cell types in culture. The resulting product, tBID, targets the organelle and induces cytochrome c release.4,5,6 This signaling event in the Fas/TNFR1 pathway is likely an important contribution to apoptosis only in type II cells in culture, where upstream induction of the pathway following receptor-mediated activation of caspase-8 may be amplified via mitochondrial transformations.15 Further, such amplification by mitochondria may involve additional factors that operate in parallel to BID.16
BAX, like BID, is constrained from targeting membrane sites, including mitochondria, until the cell receives a death signal.9,17,18 In the absence of such a signal, BAX adopts a conformation in which the COOH-terminal transmembrane signal-anchor domain of BAX cannot insert into membranes, and this is dependent at least in part on the NH2-terminal ART (Apoptotic Regulation of Targeting) domain. This repression by ART is relieved by a death stimulus and the signal-anchor now inserts BAX into mitochondrial membrane.9 Membrane insertion is accompanied by a conformational change in the protein, in which the NH2-terminus of BAX now becomes exposed.19 Alternatively, BAX translocation can be uncoupled from death signals by forced overexpression18,20,21 or forced dimerization.18 Such induced translocation of BAX results in mitochondrial permeability transition18,22 and in some contexts causes cytochrome c release.21,23 Moreover, BID and BAX can interact19,24 and both molecules can induce loss of mitochondrial integrity by mechanisms inhibited by BCL-2 proteins.4,5,18,19,25,26
Here, we have studied the mechanism that stimulates BAX insertion into mitochondria following a death signal. We demonstrate that caspase-generated p15 tBID, either directly or indirectly, releases inhibition of the COOH-terminal signal anchor of BAX by the NH2-terminal ART domain, and mediates BAX membrane integration. In certain cell types, however, parallel pathway(s) exist to achieve the same end.
Results
Activation of Fas causes recruitment of initiator procaspase-8 into the death-inducing signaling complex (DISC) via the adaptor molecule FADD.27,28,29 This stimulates autoactivation of procaspase-829,30 which then initiates an apoptotic pathway that, in type II cells in culture, involves a mitochondrial-dependent amplification of caspase activation.15,31 Recent genetic analysis32,33 has revealed that caspase-8 is an obligate and non-redundant constituent at the apex of this pathway. In Figure 1A, type II human KB epithelial cells were mock-treated or treated with agonistic anti-Fas antibody in the presence of cycloheximide,34 and BAX in whole cell lysate or in a heavy membrane fraction enriched in mitochondria9 was detected by immunoblotting. Activation of Fas resulted in neither an increase in levels of total cellular BAX (cell lysate) nor in the amount of BAX recovered with mitochondria. Extraction of these mitochondria with 0.1 Na2CO3, pH 11.5, however, which liberates proteins that are peripherally associated with the surface of membranes but retains proteins that are integrated into the lipid bilayer,35 revealed significant differences. Whereas TOM20, a protein import receptor constitutively integrated into the lipid bilayer of the outer membrane by a single transmembrane domain,36 was equally resistant to alkaline extraction in mitochondria obtained from cells with or without Fas stimulation, BAX resisted alkaline extraction only in mitochondria from Fas-stimulated cells. Membrane integration of BAX was abolished, however, when Fas-stimulation was conducted in the presence of the wide-spectrum caspase inhibitor, zVAD-fmk. We conclude, therefore, that upstream caspase-8 in the Fas pathway can initiate a caspase-dependent pathway for BAX integration into mitochondrial membrane. Furthermore, murine tBid, which is generated by cleavage of p22 Bid by caspase-8 in the Fas pathway, also stimulated BAX integration into mitochondrial membrane when expressed ectopically in human H1299 epithelial cells in the absence of Fas stimulation, whereas a BH3-defective mutant of tBid, in which leu at position 90 within helix 3 was replaced with gly,5 did not (Figure 1B).
Reconstitution of caspase-dependent insertion of BAX into mitochondria in vitro
Consistent with the findings from Fas-stimulated KB cells, treatment of a control cytosol fraction from human HeLa epithelial cells9 with caspase-8 induced the endogenous BAX in this fraction, when combined with purified rat heart mitochondria, to acquire resistance to alkali extraction, as assessed by immunoblotting (Figure 2B, lanes 1 and 2). Heart mitochondria were employed for these analyses because they can be isolated intact and contain negligible amounts of associated Bax, as determined by immunoblotting (not shown). As well, the treated extracts were capable of subsequently cleaving exogenous PARP (not shown), indicating that caspases were in fact active. A similar amount of alkali-resistant BAX was observed upon dATP-activation of the endogenous caspases in HeLa extract at 37°C,9,37 followed by incubation of the extract with mitochondria in the presence of the pan caspase inhibitor, zVAD-fmk (lane 5). In contrast, if zVAD-fmk was added to the extract prior to activation of endogenous caspases with dATP, BAX insertion into mitochondria was ablated (lane 4). Therefore, caspase(s) induce BAX membrane insertion by acting on a pre-existing constituent in the HeLa cell extract. Similar results were obtained for the influence of the zVAD-treated HeLa cell extract on membrane insertion of the 35S-labeled, full-length BAX translation product (Figure 2A). Again, zVAD was inhibitory when added prior to dATP-dependent activation of extract caspases at 37°C (lane 4) but not when added after caspase activation (lane 5). In contrast, generation of the apoptotic 24 kDa caspase cleavage product of PARP was inhibited by zVAD-fmk in either circumstance (lanes 4 and 5). Of note, deletion of the NH2-terminal 19 amino acid ART domain from BAX9 allowed [35S]BAXΔART to bypass the requirement for the caspase-activated factor, and this was true if the BAXΔART translation product was presented to mitochondria either alone (Figure 2C) or together with full length BAX (Figure 2A,C).
Molecular seive chromatography indicated that most of the [35S]BAX translation product existed as a monomer (data not shown), consistent with the observations in vivo for the cytosolic form of the protein.17,18 Incubation of this translation product with activated HeLa extract did not result in either cleavage of BAX or induction of a higher order structure. Though not conclusive, this suggests that the cytosolic factor influences BAX targeting either indirectly or at the level of the mitochondrion. Consistent with the latter, incubation of mitochondria with activated extract, followed by their re-isolation and subsequent incubation of these activated mitochondria in a standard BAX import reaction, in the absence of HeLa extract, revealed BAX insertion into mitochondrial membrane to a similar extent as for BAX import conducted with control mitochondria in the continued presence of activated extract (Figure 2D, lanes 3 and 4). This suggests that the caspase-regulated factor either associates with mitochondria or modifies a constituent of the organelle requisite for BAX membrane insertion, or both.
The caspase-regulated factor is BID
Partial purification of the caspase regulated factor in HeLa cell extracts revealed a BAX mitochondrial-insertion stimulating activity associated with a ∼15 kDa protein (data not shown). BID's NH2-terminal domain is removed by caspases, including caspase-8, to yield p15 tBID, which then targets mitochondria and induces mitochondrial dysfunction.4,5,6 When BID was removed from HeLa cell extract by immunodepletion with antibody against BID prior to activation of caspases (Figure 3A, right panel lane 3), the ability of the endogenous BAX in these extracts to insert into mitochondrial membrane was lost upon subsequent caspase activation (left panel, lane 3). Addition of recombinant BID to these BID-depleted extracts reinstated BAX membrane insertion following activation of endogenous caspases (left panel, lane 4). Moreover, direct addition of low concentrations (12 nM) of recombinant tBID, generated by caspase-8 cleavage of full length BID,5 to in vitro translated [35S]BAX could replace the requirement for activated extract and on its own stimulated [35S]BAX insertion into mitochondrial membrane (Figure 3B, lane 8). Full length BID was also stimulatory, but only at higher concentrations (lane 6). Likewise, full length BID can stimulate release of cytochrome c from mitochondria, but at concentrations higher than that of p15 tBID.4,5,6 Consistent with the results using cell extracts (Figure 2A,C), however, membrane insertion of [35S]BAXΔART did not depend on and was not further stimulated by either BID or tBID, even at high concentrations of tBID (Figure 3B).
Effect of Bid gene deletion in mouse embryo fibroblasts
Previous analysis of embryonic fibroblasts from the Bid−/− mouse revealed only a slight delay in cell killing in response to TNFα compared to Bid +/+ cells, yet a significant inhibition of cytochrome c release from mitochondria in the Bid-null cells was observed.38 Similarly, Bid−/− mouse embryo fibroblasts were delayed in cell killing following expression of E1A oncoprotein (Figure 4A) yet, again, there was an inhibition of cytochrome c release from mitochondria as assessed by confocal microscopy, although the organelle did assume a condensed morphology as a consequence of E1A expression (Figure 4B). Analysis of the high-speed supernatant fraction from E1A-stimulated cells by immunoblotting likewise showed an inhibition of cytochrome c release to the cytosol in Bid−/− cells (Figure 4C). Of note, however, E1A expression resulted in Bax insertion into mitochondrial membrane to a similar extent in Bid−/− and Bid +/+ cells over the time course examined (Figure 4D). This lack of difference between the two cell types was evident even though E1A stimulated Bid cleavage in the wild-type cells (Figure 4A, inset). Likewise, TNFα treatment stimulated Bax insertion into mitochondrial membrane to the same extent in Bid−/− and Bid +/+ cells. Thus, in both cases cell death and Bax insertion into mitochondria can bypass the requirement for Bid in this murine cell type.
Discussion
Under normal physiological conditions, BAX membrane insertion is regulated and tied to specific signal transduction events.9,17,18 In the absence of death signals, BAX adopts a conformation in which the COOH-terminal transmembrane-signal anchor is repressed and incapable of targeting the protein to mitochondria.9,10 We show here that activation of caspases, both in vivo and in vitro, can over-ride this inhibition and BAX now inserts into mitochondrial membrane. This contribution by caspases may reflect an initiation and/or amplification of regulated BAX targeting. Further, we find that caspase-generated tBID is a direct stimulus of BAX insertion into mitochondrial membrane in vitro and can initiate BAX membrane insertion in vivo in the absence of other death signals. This dependence of BAX membrane insertion on tBID was bypassed, however, by deleting the BAX NH2 ART domain. Deletion of the ART domain also enhanced the toxicity of BAX in transfected cells.9 Therefore, at least in certain contexts, caspase-generated tBID is an upstream stimulus of BAX targeting that, directly or indirectly, can relieve repression of the COOH-terminal BAX transmembrane signal-anchor segment by the NH2-terminal ART domain,9 permitting BAX integration into mitochondrial membrane (Figure 5). A number of point mutations within different regions in BAX, including the NH2-terminal39 and COOH-terminal domains,10 and the putative pore-forming helices 5 and 6,40 can also bypass the requirement for such regulation and permit constitutive targeting of BAX to mitochondria, as can exposure of the wild-type protein to elevated pH.39 As well, it will be interesting to learn if other BH3 domain-only proteins, such as BAD and BIM, can act like tBID and induce BAX targeting. It may be that the ‘closed’ inactive conformation of BAX, which correlates with inaccessibility of the NH2-terminal domain to added protease,9,19 can be perturbed or accessed by a variety of both intrinsic and extrinsic factors in addition to tBID, a situation that presumably accounts for the ability of Bid−/− mouse embryo fibroblasts to support Bax membrane insertion in response to different death signals. Additionally, however, our findings revealed that, in the absence of Bid, insertion of Bax into mitochondria did not result in release of cytochrome c from the organelle, indicating that the well-documented ability of Bax to stimulate cytochrome c release may depend on cooperation with Bid in vivo.
The role of BID and other potential regulators in controlling BAX targeting to mitochondria must be interpreted in the context of two conditions that enable BAX to bypass such regulation in vivo. Forced over-expression20,21,22 and forced dimerization18 of BAX both result in constitutive mitochondrial integration and cell death.1 Overexpression might saturate an inhibitory pathway of BAX membrane integration, a role that has been ascribed to anti-apoptotic BCL-2/BCL-XL family members.18 In this context, tBID might inactivate the BCL-2 death suppressors4,5,6 (Figure 5). Likewise, forced dimerization might preclude the influence of BCL-2 suppressors on BAX distribution, or cause a conformational change in BAX that bypasses regulation of its targeting to mitochondria.
A second possibility is that tBID takes a more direct role in BAX integration into mitochondria.19,41 For example, it may act as a receptor for BAX, inducing a conformational change in BAX and subsequent membrane insertion (Figure 5). In this scenario, BCL-2-related suppressors, if in excess, may bind and inactivate tBID. This model is consistent with studies in vitro showing that recombinant full-length BID can interact directly with BAX and support both BAX insertion into mitochondria and subsequent release of cytochrome c from the organelle.19,41 It is not clear, however, how this model reconciles with manipulations to BAX (e.g., over-expression) that allows BAX to bypass the requirement for tBID as receptor or, conversely, with Bax membrane insertion being observed in stimulated Bid-null mouse embryo fibroblasts.
Finally, integration of tBID into mitochondria might exert influences beyond the regulation of other BCL-2 family members. For example, ion channel activity of tBID has been detected in vitro.42 Also, the involvement of regulators in the endoplasmic reticulum that influence BAX activity has been recorded.43 Further insights into the role of tBID in regulating BAX membrane insertion will undoubtedly emerge by elucidating the structural basis for this influence by tBID and by assessing the potential requirement for other factor(s) in this pathway.
Materials and Methods
General
Earlier studies describe the routine procedures for cell culture and infection with adenovirus type 5 dl52OE1B− expressing only 12S E1A and no E1B products),44,45 and conducting immunocytochemistry by confocal microscopy, synthesizing [35S]BAX transcription-translation product in reticulocyte lysate, and isolating mitochondria from rat heart and cultured cells.9
Insertion of BAX into mitochondrial membrane in vitro
Apoptotic cell extracts were prepared from HeLa cells exactly as described by Goping et al.9 Twenty μl of extract (approximately 10 mg protein/ml), either alone or with 5 μl of 35S-methionine-labeled Bax transcription-translation product or 5 μl of extract buffer, were incubated in a standard protein import reaction (50 μl) containing purified mitochondria from rat heart (1.0 mg protein/ml).9 Alternatively, the cell extraction buffer (20 μl) alone replaced the extract in control reactions. The reaction mixtures were incubated for 60 min at 37°C in the absence of additives, or containing 1 mM dATP (extract/dATP), or containing 1 mM dATP and 50 μM tetrapeptide zVAD-fmk added either at the beginning (extract/dATP+zVAD-fmk) or at the end (pre-activated extract/dATP+zVAD-fmk) of the incubation period. The mitochondria were recovered by centrifugation9 and were analyzed by SDS–PAGE and fluorography to detect [35S]Bax or by immunoblotting with rabbit anti-BAX N20 antibody (Santa Cruz) to detect BAX derived from the HeLa cell extract. Analysis of rat heart mitochondria alone by immunoblotting revealed negligible Bax associated with the organelle. Alternatively, mitochondria isolated from reaction mixtures were resuspended (0.25 mg protein/ml) in freshly prepared 0.1 M Na2CO3, pH 11.5, and incubated for 30 min on ice. The membranes were then collected in an airfuge operating at 30 p.s.i. for 10 min prior to analysis by fluorography or immunoblotting.
Cytochrome c
Cells (4×106) were washed in PBS and suspended in 0.1 ml HIM buffer (200 mM mannitol, 70 mM sucrose, 1 mM EDTA, 10 mM HEPES, pH 7.5). After one cycle of freeze and thaw, the cells were homogenized with 25 strokes in a motorized Teflon-glass homogenizer operating at 500 r.p.m., and centrifuged at 800×g for 10 min to remove nuclei and cell debris. The supernatant was centrifuged at 100 000×g for 10 min and aliquots from equivalent numbers of cells were subjected to SDS–PAGE and immunoblotting with mouse monoclonal 7H8.2C12 anti-cytochrome c.
Bid-null mouse embryo fibroblasts
Mouse embryo fibroblasts were prepared from 9.5 day-old embryos of mice carrying a homozygous deletion in the coding region of Bid.38 They were cultured in Iscove's modified Dulbecco's medium containing 20% fetal calf serum, and infected with adenovirus type 5 dl52OE1B− (expressing only 12S E1A and no E1B products) or treated with TNFα, as described.38,46
Abbreviations
- ART:
-
apoptotic regulation of BAX targeting
References
Gross A, McDonnell JM and Korsmeyer SJ . 1999 Bcl-2 family members and the mitochondria in apoptosis. Genes Dev. 13: 1899–1911
Adams JM and Cory S . 1998 The Bcl-2 protein family: arbiters of cell survival. Science 281: 1322–1326
Zha J, Harada H, Yang E, Jockel J and Korsmeyer SJ . 1996 Serine phosphorylation of death agonist Bad in response to survival factor results in binding to 14-3-3 not Bcl-X. Cell 87: 619–626
Luo X, Budihardji I, Zou H, Slaughter C and Wang X . 1998 Bid, a Bcl2 interacting protein, mediates cytochrome c release from mitochondria in response to activation of cell surface death receptors. Cell 94: 481–490
Li H, Zhu H, Xu C-J and Yuan J . 1998 Cleavage of Bid by caspase 8 mediates the mitochondrial damage in the Fas pathway of apoptosis. Cell 94: 491–501
Gross A, Yin X-M, Wang K, Wei MC, Jockel J, Milliman C, Erdjument-Bromage H, Tempst P and Korsmeyer SJ . 1999 Caspase cleaved Bid targets mitochondria and is required for cytochrome c release, while Bcl-XL prevents this release but not tumor necrosis factor-R1/Fas Death. J. Biol. Chem. 274: 1156–1163
Puthalakath H, Huang DCS, O'Reilly LA, King SM and Strasser A . 1999 The proapoptotic activity of the Bcl-2 family member Bim is regulated by interaction with the dynein motor complex. Mol. Cell 3: 287–296
Nguyen M, Miller DG, Yong VW, Korsmeyer SJ and Shore GC . 1993 Targeting of Bcl-2 to the mitochondrial outer membrane by a COOH-terminal signal sequence. J. Biol. Chem. 268: 25265–25268
Goping IS, Gross A, Lavoie JN, Nguyen M, Jemmerson R, Roth K, Korsmeyer SJ and Shore GC . 1998 Regulated targeting of Bax to mitochondria. J. Cell Biol. 143: 207–215
Nechestan A, Smith CL, Hsu Y-T and Youle RJ . 1999 Conformation of the BAX c-terminus regulates subcellular location and cell death. EMBO J. 18: 2330–2341
Green DR and Reed JC . 1998 Mitochondria and apoptosis. Science 281: 1309–1312
Yang J, Siu X, Bhalla K, Kim CN, Ibrado AM, Cai J, Peng T-I, Jones DP and Wang X . 1997 Prevention of apoptosis by Bcl-2: release of cytochrome c from mitochondria blocked. Science 275: 1129–1132
Kluck RM, Bossy-Wetzel E, Green DR and Newmeyer DD . 1997 The release of cytochrome c from mitochondria: a primary site for Bcl-2 regulation of apoptosis. Science 275: 1132–1136
Li P, Nijhawan D, Budihardjo I, Srinivasula SM, Ahmad M, Alnemri ES and Wang X . 1997 Cytochrome c and dATP-dependent formation of Apaf-1/caspase-9 complex initiates an apoptotic protease cascade. Cell 91: 479–489
Scaffidi C, Fulda S, Srinivasan A, Friesen C, Li F, Tomaselli KJ, Debatin K-M, Krammer PH and Peter ME . 1998 Two CD95 (APO-1/Fas) signaling pathways. EMBO J. 17: 1675–1687
Bossy-Wetzel E and Green DR . 1999 Caspases induce cytochrome c release from mitochondria by activating cytosolic factors. J. Biol. Chem. 274: 17484–17490
Hsu Y-T, Wolter KG and Youle RJ . 1997 Cytosol-to-membrane redistribution of Bax and Bcl-XL during apoptosis. Proc. Natl. Acad. Sci. USA 94: 3668–3672
Gross A, Jockel J, Wei MC and Korsmeyer SJ . 1998 Enforced dimerization of Bax results in its translocation, mitochondrial dysfunction and apoptosis. EMBO J. 17: 3878–3885
Desagher S, Osen-Sand A, Nichols A, Eskes R, Montessuit S, Lauper S, Maundrell K, Antonsson B and Martinou J-C . 1999 Bid-induced conformational change of Bax is responsible for mitochondrial cytochrome c release during apoptosis. J. Cell Biol. 144: 891–901
Xiang J, Chao DT and Korsmeyer SJ . 1996 BAX-induced cell death may not require interleukin 1β-converting enzyme-like proteases. Proc. Natl. Acad. Sci. USA 93: 14559–14563
Rossé T, Oliver R, Monney L, Roger M, Conus S, Fellay I, Jansen B and Borner C . 1998 Bcl-2 prolongs cell survival after Bax-induced release of cytochrome c. Nature 391: 496–499
Wang K, Gross A, Waksman G and Korsmeyer SJ . 1998 Mutagenesis of the BH3 domain of Bax identifies residues critical for dimerization and killing. Mol. Cell. Biol. 18: 6083–6089
Eskes R, Antonsson B, Osen-Sand A, Montessuit S, Richter C, Sadoul R, Mazzei G, Nichols A and Martinou J-C . 1998 Bax-induced cytochrome c release from mitochondria is independent of the permeability transition pore but highly dependent on Mg2+ ions. J. Cell. Biol. 143: 217–224
Wang K, Yin X-M, Chao DT, Milliman CL and Korsmeyer SJ . 1996 BID: a novel BH3 domain-only death agonist. Genes Dev. 10: 2859–2869
Finucane DM, Bossy-Wetzel E, Waterhouse NJ, Cotter TG and Green DR . 1999 Bax-induced caspase activation and apoptosis via cytochrome c release from mitochondria is inhibitable by Bcl-XL . J. Biol. Chem. 274: 2225–2233
Jürgensmeier JM, Xie Z, Devereaux D, Ellerby L, Bredesen D and Reed JC . 1998 Bax directly induces release of cytochrome c from isolated mitochondria. Proc. Natl. Acad. Sci. USA 95: 4997–5002.
Kischkel FC, Hellbardt S, Behrmann I, Germer M, Pawlita M, Krammer PH and Peter ME . 1995 Cytotoxicity-dependent APO-1 (Fas/CD95)-associated proteins form a death-inducing signaling complex (DISC) with the receptor. EMBO J. 14: 5579–5588
Boldin MP, Goncharov TM, Goltsev YV and Wallach D . 1996 Involvement of MACH, a novel MORT1/FADD-interacting protease, in Fas/APO-1- and TNF receptor-induced cell death. Cell 85: 803–815
Muzio M, Chinnaiyan AM, Kischkel FC, O'Rourke K, Shevchenko A, Ni J, Scaffidi C, Bretz JD, Zhang M, Gentz R, Mann M, Krammer PH, Peter ME and Dixit VM . 1996 FLICE, a novel FADD-homologous ICE/CED-3-like protease, is recruited to the CD95 (Fas/APO-1) death-inducing signaling complex. Cell 85: 817–827
Medema JP, Scaffidi C, Kischkel FC, Shevchenko A, Mann M, Krammer PH and Peter ME . 1997 FLICE is activated by association with the CD95 death-inducing signaling complex (DISC). EMBO J. 16: 2794–2804
Boise LH and Thompson CB . 1997 Bcl-X(L) can inhibit apoptosis in cells that have undergone Fas-induced protease activation. Proc. Natl. Acad. Sci. USA 94: 3759–3764
Varfolomeev EE, Schuchmann M, Luria V, Chiannilkulchai N, Beckmann JS, Mett IL, Rebrikov D, Brodianski VM, Kemper OC, Kollet O, Lapidot T, Soffer D, Sobe T, Avraham KB, Goncharov T, Holtmann H, Lonia P and Wallach D . 1998 Targeted disruption of the mouse caspase 8 gene ablates cell death induction by the TNF receptors, Fas/APO-1, and DR3 and is lethal prenatally. Immunity 9: 267–276
Juo P, Kuo CJ, Yuan J and Blenis J . 1998 Essential requirements for caspase-8/FLICE in the initiation of the Fas-induced apoptotic cascade. Curr. Biol. 8: 1001–1008
Scaffidi C, Schmitz I, Zha J, Korsmeyer SJ, Krammer PH and Peter ME . 1999 Differential modulation of apoptosis sensitivity in CD95 type I and type II cells. J. Biol. Chem. 274: 22532–22538
Fujiki Y, Fowler S, Shio H, Hubbard AL and Lazarow P . 1982 Polypeptide and phospholipid composition of the membrane of rat liver peroxisomes: comparison with endoplasmic reticulum and mitochondrial membranes. J. Cell Biol. 93: 103–110
McBride HM, Goping IS and Shore GC . 1996 The human mitochondrial import receptor, hTom20p, prevents a cryptic matrix targeting sequence from gaining access to the protein translocation machinery. J. Cell Biol. 134: 307–313
Liu X, Kim CN, Yang J, Jemmerson R and Wang X . 1996 Induction of apoptotic program in cell-free extracts: requirement for dATP and cytochrome c. Cell 86: 147–157
Yin X-M, Wang K, Gross A, Zhao Y, Zinlle S, Klocke B, Roth KA and Korsmeyer SJ . 1999 Bid-deficient mice are resistant to Fas-induced hepatocellular apoptosis. Nature 400: 886–891
Khaled AR, Kim K, Hofmeister R, Muegge K and Durum SK . 1999 Withdrawal of IL-7 induces Bax translocation from cytosol to mitochondria through a rise in intracellular pH. Proc. Natl. Acad. Sci. USA 96: 14476–14481
Nouraini S, Six E, Matsuyama S, Krajewski S and Reed JC . 2000 The putative pore-forming domain of Bax regulates mitochondrial localization and interaction with Bcl-XL . Mol. Cell. Biol. 20: 1604–1615
Eskes R, Desagher S, Antonsson B and Martinou J-C . 2000 Bid induces the oligomerization and insertion of Bax into the outer mitochondrial membrane. Mol. Cell. Biol. 20: 929–935
Schendel SL, Azimov R, Pawlowski K, Godzig A, Kagan BL and Reed JC . 1999 Ion channel activity of the BH3 only Bcl-2 family member, BID. J. Biol. Chem. 274: 21932–21936
Xu Q and Reed JC . 1998 Bax inhibitor-1, a mammalian apoptosis suppressor identified by functional screening in yeast. Mol. Cell 1: 337–346
Boulakia CA, Chen G, Ng FWH, Teodoro JG, Branton PE, Nicholson DW, Poirier GG and Shore GC . 1996 Bcl-2 and adenovirus E1B 19 kDa protein prevent E1A-induced processing of CPP32 and cleavage of Poly(ADP-ribose) polymerase. Oncogene 12: 529–535
Ng FWH, Nguyen M, Kwan T, Branton PE, Nicholson DW, Cromlish JA and Shore GC . 1997 p28 Bap31, a Bcl-2/Bcl-XL- and procaspase-8-associated protein in the endoplasmic reticulum. J. Cell. Biol. 139: 327–338
Nguyen M, Branton PE, Roy S, Nicholson DW, Alnemri ES, Yeh W-C, Mak TW and Shore GC . 1998 E1A-induced processing of procaspase-8 can occur independently of FADD and is inhibited by Bcl-2. J. Biol. Chem. 273: 33099–33102
Acknowledgements
This work was supported by operating grants from the Medical Research Council and National Cancer Institute of Canada. HeLa cells were obtained from the National Cell Culture Center, Minneapolis, Minnesota. SC Ruffolo was supported by fellowships from FCAR-FRSQ and MRC, and DG Breckenridge by the Max Stern Recruitment Fellowship from McGill University and MRC.
Author information
Authors and Affiliations
Corresponding author
Additional information
Edited by JM Hardwick
Rights and permissions
About this article
Cite this article
Ruffolo, S., Breckenridge, D., Nguyen, M. et al. BID-dependent and BID-independent pathways for BAX insertion into mitochondria. Cell Death Differ 7, 1101–1108 (2000). https://doi.org/10.1038/sj.cdd.4400739
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.cdd.4400739
Keywords
This article is cited by
-
Suppression of PI3K/Akt signaling by synthetic bichalcone analog TSWU-CD4 induces ER stress- and Bax/Bak-mediated apoptosis of cancer cells
Apoptosis (2014)
-
Silencing of HIF-1α suppresses tumorigenicity of renal cell carcinoma through induction of apoptosis
Cancer Gene Therapy (2010)
-
The Bax carboxy-terminal hydrophobic helix does not determine organelle-specific targeting but is essential for maintaining Bax in an inactive state and for stable mitochondrial membrane insertion
Apoptosis (2010)
-
Cisplatin enhances the antitumor effect of tumor necrosis factor-related apoptosis-inducing ligand gene therapy via recruitment of the mitochondria-dependent death signaling pathway
Cancer Gene Therapy (2008)
-
The role of the mitochondria in mediating cytotoxicity of anti-cancer therapies
Journal of Bioenergetics and Biomembranes (2007)